Clinical trials
Observational Crohn Disease trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
119 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 6 |
| 2013 | 2 |
| 2014 | 6 |
| 2015 | 7 |
| 2016 | 5 |
| 2017 | 9 |
| 2018 | 8 |
| 2019 | 12 |
| 2020 | 7 |
| 2021 | 14 |
| 2022 | 17 |
| 2023 | 9 |
| 2024 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 119 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tel-Aviv Sourasky Medical Center | 6 |
| Chinese University of Hong Kong | 4 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 4 |
| Ced Service GmbH | 3 |
| Istituto Clinico Humanitas | 3 |
| Cedars-Sinai Medical Center | 2 |
| Central Hospital, Nancy, France | 2 |
| Corporacion Parc Tauli | 2 |
| Eli Sprecher, MD | 2 |
| Hospital Mutua de Terrassa | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Crohn Disease | 119 |
| Colitis, Ulcerative | 51 |
| Inflammatory Bowel Diseases | 33 |
| Arthritis, Rheumatoid | 9 |
| Spondylitis, Ankylosing | 7 |
| Arthritis, Psoriatic | 6 |
| Irritable Bowel Syndrome | 5 |
| Psoriasis | 4 |
| Fibromyalgia | 3 |
| Fistula | 3 |
Trials
Showing 1 to 25 of 119. Each trial links to its page on Pharma Observatory.
19 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.